1. Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors.

    PMID 26612422 PMCID PMC4946049

    The type 1 cannabinoid receptor (CB1) modulates numerous neurobehavioral processes and is therefore explored as a target for the treatment of several mental and neurological diseases. However, previous studies have investigated CB1 by targeting it globally, regardless of its two main neuronal lo...
  2. Nalmefene is effective at reducing alcohol seeking, treating alcohol-cocaine interactions and reducing alcohol-induced histone deacetylases gene expression in blood.

    British journal of pharmacology and chemotherapy 173(16):2490 (2016) PMID 27238566 PMCID PMC4959953

    The opioid antagonist nalmefene (selincro®) was approved for alcohol-related disorders by the European Medicines Agency in 2013. However, there have been no studies regarding the effectiveness of nalmefene when alcohol is used in combination with cocaine. Using operant alcohol self-administratio...
  3. Epigenetics, behavior and early nicotine.

    Nature Neuroscience 19(7):863 (2016) PMID 27351169

  4. Role of β4* Nicotinic Acetylcholine Receptors in the Habenulo-Interpeduncular Pathway in Nicotine Reinforcement in Mice.

    PMID 26585290 PMCID PMC4869047

    Nicotine exerts its psychopharmacological effects by activating the nicotinic acetylcholine receptor (nAChR), composed of alpha and/or beta subunits, giving rise to a diverse population of receptors with a distinct pharmacology. β4-containing (β4*) nAChRs are located almost exclusively in the ha...
  5. Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ(9) -tetrahydrocannabinol.

    British journal of pharmacology and chemotherapy 173(8):1381 (2016) PMID 26799708 PMCID PMC4940815

    Anatomical, biochemical and pharmacological evidence suggest the existence of a crosstalk between the orexinergic and endocannabinoid systems. While the orexin receptor 1 (OX1 receptor) modulates the reinforcing properties of cannabinoids, the participation of orexins in the acute pharmacologica...
  6. The endocannabinoid system and neuropathic pain.

    PAIN® 157 Suppl 1:S23 (2016) PMID 26785153

    The research of new therapeutic strategies for neuropathic pain represents a major current priority. Important drawbacks to advance in the development of these therapies are the limited translational value of the animal models now available and the elucidation of the complex neuronal and immune ...
  7. Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.

    Journal of Alzheimer's Disease 51(2):489 (2016) PMID 26890764

    The endogenous cannabinoid system represents a promising therapeutic target to modify neurodegenerative pathways linked to Alzheimer's disease (AD). The aim of the present study was to evaluate the specific contribution of CB2 receptor to the progression of AD-like pathology and its role in the ...
  8. The endocannabinoid system in guarding against fear, anxiety and stress.

    Nature Reviews: Neuroscience 16(12):705 (2015) PMID 26585799

    The endocannabinoid (eCB) system has emerged as a central integrator linking the perception of external and internal stimuli to distinct neurophysiological and behavioural outcomes (such as fear reaction, anxiety and stress-coping), thus allowing an organism to adapt to its changing environment....
  9. Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-Like Behavior.

    PMID 25944409 PMCID PMC4864655

    An increasing perspective conceptualizes obesity and overeating as disorders related to addictive-like processes that could share common neurobiological mechanisms. In the present study, we aimed at validating an animal model of eating addictive-like behavior in mice, based on the DSM-5 substanc...
  10. Histone Deacetylase Gene Expression Following Binge Alcohol Consumption in Rats and Humans.

    Alcoholism: Clinical and Experimental Research 39(10):1939 (2015) PMID 26365275

    Alcohol binge drinking is one of the most common patterns of excessive alcohol use and recent data would suggest that histone deacetylases (HDACs) gene expression profiling could be useful as a biomarker for psychiatric disorders. This study aimed to characterize the gene expression patterns of ...
  11. Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain.

    PAIN® 156(10):2001 (2015) PMID 26067584 PMCID PMC4770330

    In this study, we investigated the role of the endocannabinoid system (ECS) in the emotional and cognitive alterations associated with osteoarthritis pain. The monosodium iodoacetate model was used to evaluate the affective and cognitive manifestations of osteoarthritis pain in type 1 (CB1R) and...
  12. Differential regulation of mGlu5 R and ΜOPr by priming- and cue-induced reinstatement of cocaine-seeking behaviour in mice.

    Addiction Biology 20(5):902 (2015) PMID 25522112

    The key problem for the treatment of drug addiction is relapse to drug use after abstinence that can be triggered by drug-associated cues, re-exposure to the drug itself and stress. Understanding the neurobiological mechanisms underlying relapse is essential in order to develop effective pharmac...
  13. Orexins and fear: implications for the treatment of anxiety disorders.

    Trends in Neurosciences 38(9):550 (2015) PMID 26216377

    An understanding of the neurobiological mechanisms involved in the regulation of fear is essential for the development of new treatments for anxiety disorders, such as phobias, panic, and post-traumatic stress disorders (PTSD). Orexins, also known as hypocretins, are neuropeptides located exclus...
  14. Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors.

    PLoS Biology 13(7):e1002194 (2015) PMID 26158621 PMCID PMC4497644

    Activation of cannabinoid CB1 receptors (CB1R) by delta9-tetrahydrocannabinol (THC) produces a variety of negative effects with major consequences in cannabis users that constitute important drawbacks for the use of cannabinoids as therapeutic agents. For this reason, there is a tremendous medic...
  15. Physiological Control of Nitric Oxide in Neuronal BACE1 Translation by Heme-Regulated eIF2α Kinase HRI Induces Synaptogenesis.

    Antioxidants and Redox Signaling 22(15):1295 (2015) PMID 25706765

    Hippocampus is the brain center for memory formation, a process that requires synaptogenesis. However, hippocampus is dramatically compromised in Alzheimer's disease due to the accumulation of amyloid β-peptide, whose production is initiated by β-site APP Cleaving Enzyme 1 (BACE1). It is known t...
  16. Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.

    Pharmacology research & perspectives 3(2):e00116 (2015) PMID 25692029 PMCID PMC4324690

    The peripheral endogenous opioid system is critically involved in neuropathic and inflammatory pain generation as suggested by the modulation of opioid receptors expression and enkephalins (ENKs) release observed in these painful conditions. Accordingly, an innovative approach in the treatment o...
  17. A novel anxiogenic role for the delta opioid receptor expressed in GABAergic forebrain neurons.

    Biological Psychiatry 77(4):404 (2015) PMID 25444168 PMCID PMC4297504

    The delta opioid receptor (DOR) is broadly expressed throughout the nervous system; it regulates chronic pain, emotional responses, motivation, and memory. Neural circuits underlying DOR activities have been poorly explored by genetic approaches. We used conditional mouse mutagenesis to elucidat...
  18. 5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence.

    International Journal of Neuropsychopharmacology 18(3) (2015) PMID 25522398 PMCID PMC4360241

    Desensitization and blockade of 5-HT2C receptors (5-HT2CR) have long been thought to be central in the therapeutic action of antidepressant drugs. However, besides behavioral pharmacology studies, there is little in vivo data documenting antidepressant-induced 5-HT2CR desensitization in specific...
  19. Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice.

    Journal of Alzheimer's Disease 43(3):977 (2015) PMID 25125475

    Several recent findings suggest that targeting the endogenous cannabinoid system can be considered as a potential therapeutic approach to treat Alzheimer's disease (AD). The present study supports this hypothesis demonstrating that delta-9-tetrahydrocannabinol (THC) or cannabidiol (CBD) botanica...
  20. Frustrated expected reward induces differential transcriptional changes in the mouse brain.

    Addiction Biology 20(1):22 (2015) PMID 25288320

    Frustration represents a particular aspect of the addictive process that is related to loss of control when the expected reward is not obtained. We aim to study the consequences of frustrated expected reward on gene expression in the mouse brain. For this purpose, we used an operant model of fru...